Psychedelic Stocks,Shroom News Israeli Firm Unveils a Psychedelic Mushroom Naval Spray By Dennis Mutua May 10, 2022 Israel based biopharmaceutical company Madrigal Mental Care has unveiled novel nanotechnology to deliver psilocybin through nasal spray for treatment and prevention of post-traumatic stress disorder at Biomed Israel 2022 which too...
Psychedelic Stocks,Shroom News Psychedelic Media Firm Tripsitter.com Integrates its Platform By Dennis Mutua May 05, 2022 Psychedelics media company and educational resource and advocate for responsible use of psychedelics Tripsitter.com has announced a new look for 2022 the relaunch of the platform is already done leaving the website with overhauled...
Psychedelic Stocks,Shroom News Connecticut House Approves Proposal to Grant Certain Patients Access to Psychedelic Treatments By Dennis Mutua May 04, 2022 The Connecticut House of Representatives approved a budget bill which included provisions which grant certain patients access to psychedelics assisted therapies. According to Marijuana Moment, the psychedelics in question include;...
Psychedelic Stocks,Shroom News Researchers From UNLV to Conduct Study on Use of Psychedelics Compounds By Dennis Mutua April 28, 2022 Researchers from the University of Nevada, Las Vegas have initiated a study on psychedelics drugs such as LCD, mescaline and psilocybin among others to find out their potential mental health application of these drugs. The abov...
Psychedelic Stocks,Shroom News Sanofi Strikes a Licensing Agreement With Psychedelics Company Terran Biosciences By Dennis Mutua April 27, 2022 Multinational healthcare company Sanofi (NASDAQ: SNY) announced having inked a licensing agreement with biotechnology company developing therapeutics and technologies to treat neurological and mental illness Terran Biosciences. ...
Featured,Shroom News KCSA Psychedelics Virtual Investor Conference to be Held on April 27th and 28th By Dennis Mutua April 26, 2022 Leading proprietary investor conference series Virtual Investor Conferences (VIC) has partnered with KCSA Strategic Communications to announce the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference which has bee...
Psychedelic Stocks,Shroom News Maine Senate Approves Medical Psilocybin Proposal but House of Representatives Turns it Down By Dennis Mutua April 22, 2022 In the course of this week, the Maine Senate approved a medical psilocybin bill which is seeking to create a medical program across the state. However, the House of Representatives refused to pass the same bill. This bill was i...
Psychedelic Stocks,Shroom News MindMed Collaborators to Present Clinical Trial Results for LCD in Anxiety Disorder at PSYCH Symposium By Dennis Mutua April 19, 2022 Biopharmaceutical company developing psychedelics-inspired medicines and therapies to address addiction and brain health disorders MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced that its collaborators at University Hospital Bas...
